drug-use

Documents about drug-use

• Electronic Health Record (EHR)-Based Intervention for Gastroesophageal Reflux Disease (GERD) and Chronic Non-steroidal Anti-inflammatory Drug (NSAID) Use#889524ClinicalTrials.gov
• All Pain, No GAIN: Need for Prudent Antimicrobial Use Provisions To Complement the GAIN Act#277837Scholarly Commons at Boston University School of Law
• Implications of COVID-19 Restrictions on the Ethics and Methods of a Multi-Site Study on Alcohol and Other Drug (AOD) Use Treatment among Men in South Africa.#281579PubMed
• An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea#369957ClinicalTrials.gov
• Impact of physical activity on sleep in adults recovering from substance use disorders: a protocol for an N-of-1 observational study#405506Figshare
• Adherence to a Mediterranean diet and leisure-time physical activity are associated with reduced initiation of antidepressant, anxiolytic, antipsychotic and antiseizure drug use in older adults: a cohort study#1065107Dipòsit Digital de la Universitat de Barcelona
• Herbal medicine use disclosure, database-flagged potential herb-drug interactions, and inter – interaction database concordance among patients with non-communicable diseases in Vietnam: A multicenter cross-sectional study#418988PLOS
• An Examination of Lifetime Traumatic Brain Injury and Anti-Inflammatory Medication Use in the Risk for Alzheimer's Disease#433115DigitalCommons@USU
• “De tanto ser chamado por um nome, você acaba atendendo por ele”: o consumo de drogas nas trajetórias de vida da juventude rural do cariri paraibano#637216Repositório Institucional da UFPB
• A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)#869163ClinicalTrials.gov
• JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors#882723ClinicalTrials.gov
• fMRI Study of a Dual Process Treatment Protocol With Substance Dependent Adults#894672ClinicalTrials.gov
• Lignes directrices unifiées sur l’utilisation des antirétroviraux pour le traitement et la prévention de l’infection à VIH : recommandations pour une approche de santé publique#373049WHO IRIS
• Correction to: Ultra-Processed Food Consumption is Associated with Alcoholic Beverage Drinking, Tobacco Smoking, and Illicit Drug Use in Adolescents: A Nationwide Population-Based Study (International Journal of Mental Health and Addiction, (2023), 10.1007/s11469-023-01038-6)#948270Repositorio de Universidad Autónoma de Chile.
• Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)#1030691ClinicalTrials.gov
• Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Substance Use#966722ClinicalTrials.gov
• 21 CFR Part 361 — Prescription Drugs for Human Use Generally Recognized as Safe and Effective and Not Misbranded: Drugs Used in Research#506841Code of Federal Regulations (eCFR)
• Hi-fun, homepas and incidental sex with drugs: a qualitative study developing a locally grounded definition of hi-fun (chemsex) compared to other sexualised drug use types practiced by gay, bisexual and other men who have sex with men in Thailand.#138646NCBI PubMed Central
• Operational considerations for preventing the mother-to-child transmission (PMTCT) of HIV in the 2013 WHO consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection#466863WHO IRIS
• 49 CFR Part 219 — Control of Alcohol and Drug Use#511771Code of Federal Regulations (eCFR)
• Following the money: Mapping the sources and funding flows of alcohol and other drug treatment in Australia#190636UNSWorks Repository
• Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment#905269ClinicalTrials.gov
• Pilot Study of High-Concentration Capsaicin Patches in the Treatment of Painful HIV-Associated Neuropathy#835718ClinicalTrials.gov
• A Study to Learn How Safe Study Drug BAY2413555 is, How it Affects the Body, and How it Moves Into, Through, and Out of the Body Over 4 Weeks of Use in Participants With Heart Failure and Implanted Cardiac Defibrillator or Cardiac Resynchronization Devices (ICD/CRT)#904634ClinicalTrials.gov
• Perbandingan Kadar Merkuri dalam Darah Wanita Pengguna Krim Wajah yang Teregistrasi dan Tidak Teregistrasi Badan Pengawas Obat dan Makanan: Comparison of Mercury Levels in the Blood of Women Who Use Registered and Unregistered Indonesian National Agency of Drug and Food Control Facial Creams#1004132Jurnal Surya Medika (JSM)
• 21 CFR Part 300 — General#506811Code of Federal Regulations (eCFR)
• 49 CFR Part 655 — Prevention of Alcohol Misuse and Prohibited Drug Use in Transit Operations#511927Code of Federal Regulations (eCFR)
• 21 CFR Part 310 — New Drugs#506812Code of Federal Regulations (eCFR)
• 21 CFR Part 315 — Diagnostic Radiopharmaceuticals#506815Code of Federal Regulations (eCFR)
• 21 CFR Part 316 — Orphan Drugs#506816Code of Federal Regulations (eCFR)
• 21 CFR Part 317 — Qualifying Pathogens#506817Code of Federal Regulations (eCFR)
• Guidelines on long-acting injectable cabotegravir for HIV prevention: web annex E: predicted effects of introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study#376871WHO IRIS
• Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection#612174eScholarship
• 21 CFR Part 320 — Bioavailability and Bioequivalence Requirements#506818Code of Federal Regulations (eCFR)
• 21 CFR Part 880 — General Hospital and Personal Use Devices#506908Code of Federal Regulations (eCFR)
• Partial Post-Exposure Protection by Topical Inserts Containing Tenofovir Alafenamide Fumarate/Elvitegravir in a Macaque Model of Rectal Simian HIV (SHIV) Infection#351815ODU Digital Commons
• 21 CFR Part 105 — Foods for Special Dietary Use#506734Code of Federal Regulations (eCFR)
• 21 CFR Part 809 — In Vitro Diagnostic Products for Human Use#506889Code of Federal Regulations (eCFR)
• 21 CFR Part 189 — Substances Prohibited from Use in Human Food#506788Code of Federal Regulations (eCFR)
• Failed epidural after upper abdominal laparotomy in chronic pain patients with opioid use – a retrospective case control study#651703eScholarship
• Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma#491856eScholarship
• 21 CFR Part 511 — New Animal Drugs for Investigational Use#506849Code of Federal Regulations (eCFR)
• UC Comments on FDA's Considerations for the Use of Real-World Data and Real-World Evidence To Support Regulatory Decision-Making for Drug and Biological Products; Draft Guidance for Industry; Availability (Docket No. FDA-2021-D-1214, December 9, 2021)#629324eScholarship
• 21 CFR Part 558 — New Animal Drugs for Use in Animal Feeds#506861Code of Federal Regulations (eCFR)
• Correction: Mental Health and ART Adherence in a Multisite International Study: The Mediating Roles of Social Support and Substance Use in People with HIV#634653eScholarship
• 21 CFR Part 516 — New Animal Drugs for Minor Use and Minor Species#506852Code of Federal Regulations (eCFR)
• 21 CFR Part 589 — Substances Prohibited from Use in Animal Food or Feed#506868Code of Federal Regulations (eCFR)
• 21 CFR Part 630 — Requirements for Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use#506874Code of Federal Regulations (eCFR)
• Clinical Study of the Effectiveness, Tolerability and Safety of the Drug "Anti-spike, Gel, 100 g in Bottles in Package No. 1" Produced by the Republican Unitary Enterprise "Unitekhprom BSU", With a Single Intraperitoneal Use After Surgery in Adult Patients With Acute Phlegmonous Appendicitis#849334ClinicalTrials.gov
• 21 CFR Part 81 — General Specifications and General Restrictions for Provisional Color Additives for Use in Foods, Drugs, and Cosmetics#506727Code of Federal Regulations (eCFR)